The document discusses dissolution, which is the process by which a solid substance enters the solvent phase to form a solution. Dissolution is important for drug absorption from oral dosage forms and can be the rate-limiting step. Dissolution testing is used for quality control, formulation development, and correlating in vitro dissolution to in vivo bioavailability. Theories of dissolution include diffusion layer models and surface renewal models. Factors that affect dissolution include drug properties, dosage form factors, particle size, polymorphism, salt formation, and lipid solubility.
BIOPHARMACEUTIC CONSIDERATIONS IN DRUG PRODUCT DESIGNN Anusha
BIOPHARMACEUTICS studies the in vitro impact of physicochemical properties of drugs and drug products on delivery to body under normal or pathologic conditions.
Biopharmaceutics links the physical and chemical properties of drug and drug product to their performance, in vivo.
The aim of biopharmaceutics is to adjust the delivery of drug from drug products in such a manner as to provide: optimal therapeutic activity and safety for the patient.
BIOPHARMACEUTIC CONSIDERATIONS IN DRUG PRODUCT DESIGNN Anusha
BIOPHARMACEUTICS studies the in vitro impact of physicochemical properties of drugs and drug products on delivery to body under normal or pathologic conditions.
Biopharmaceutics links the physical and chemical properties of drug and drug product to their performance, in vivo.
The aim of biopharmaceutics is to adjust the delivery of drug from drug products in such a manner as to provide: optimal therapeutic activity and safety for the patient.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
Decomposition and stabilization of pharmaceutical productsArshad Khan
Drug stability:Stabilization of medicinal agents against common reactions like hydrolysis & oxidation. Accelerated stability testing in expiration dating of pharmaceutical dosage forms. Photolytic degradation and its prevention.
Factors affecting extraction, Pharmacognosy, crude drugs extraction factorsDivya Sree M S
Factors affecting extraction, Pharmacognosy, crude drugs extraction factors, Factors affecting choice of Extraction Process
Factors considered when selecting a solvent
The chapter deals with the preformulation studies that have to be considered while designing a dosage form and developing a formulation that is suitable for a patient. Here, physical and chemical properties of a drug substance are studied along with biopharmaceutical classification of drugs. Also a detailed study on the application of preformulation studies in different dosage forms are also studied.
Suspension is made of two phase system, consisting of a finely divided solid particles (Dispersed phase) distributed in a particular manner throughout another medium (Continuous phase).
1. Measurement of Bioavailability:
Direct and indirect methods may be used to assess drug bioavailability. The in-vivo bioavailability of a drug product is demonstrated by the rate and extent of drug absorption, as determined by comparison of measured parameters, e.g., concentration of the active drug ingredient in the blood, cumulative urinary excretion rates, or pharmacological effects.
For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action.
The design of the bioavailability study depends on the objectives of the study, the ability to analyze the drug (and metabolites) in biological fluids, the pharmacodynamics of the drug substance, the route of drug administration, and the nature of the drug product.
Pharmacokinetic and/or pharmacodynamic parameters as well as clinical observations and in-vitro studies may be used to determine drug bioavailability from a drug product.
1.1. Pharmacokinetic methods:
These are very widely used and based upon the assumption that the pharmacokinetic profile reflects the therapeutic effectiveness of a drug. Thus these are indirect methods. The two major pharmacokinetic methods are:
The major pharmacokinetic methods are:
Plasma / blood level time profile.
o Time for peak plasma (blood) concentration (t max)
o Peak plasma drug concentration (Cmax)
o Area under the plasma drug concentration–time curve (AUC)
Urinary excretion studies.
o Cumulative amount of drug excreted in the urine (Du)
o Rate of drug excretion in the urine (dDu/dt)
o Time for maximum urinary excretion (t)
C. Other biological fluids
1.2. Pharmacodynamic methods:
IT involves direct measurement of drug effect on a (patho) physiological process as a function of time. Disadvantages of it may be high variability, difficult to measure, limited choices, less reliable, more subjective, drug response influenced by several physiological & environmental factors.
They involve determination of bioavailability from:
Acute pharmacological response.
Therapeutic response.
1.3. In-vitro dissolution studies
Closed compartment apparatus
Open compartment apparatus
Dialysis systems.
1.4. Clinical observations
Well-controlled clinical trials
DISSOLUTION
Dissolution is defined as a process in which a solid substance solubilises in a given solvent.
(i.e. mass transfer from the solid surface to the liquid phase.)
Three Theories:
Diffusion layer model / Film theory
Danckwert’s model / Penetration or Surface renewal theory
Interfacial barrier model / Double barrier or Limited solvation theory
introduction
mechanisms of protein drug binding
binding of drugs
binding of drugs to blood components
determination of protein drug binding
factors affecting
significance
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
Decomposition and stabilization of pharmaceutical productsArshad Khan
Drug stability:Stabilization of medicinal agents against common reactions like hydrolysis & oxidation. Accelerated stability testing in expiration dating of pharmaceutical dosage forms. Photolytic degradation and its prevention.
Factors affecting extraction, Pharmacognosy, crude drugs extraction factorsDivya Sree M S
Factors affecting extraction, Pharmacognosy, crude drugs extraction factors, Factors affecting choice of Extraction Process
Factors considered when selecting a solvent
The chapter deals with the preformulation studies that have to be considered while designing a dosage form and developing a formulation that is suitable for a patient. Here, physical and chemical properties of a drug substance are studied along with biopharmaceutical classification of drugs. Also a detailed study on the application of preformulation studies in different dosage forms are also studied.
Suspension is made of two phase system, consisting of a finely divided solid particles (Dispersed phase) distributed in a particular manner throughout another medium (Continuous phase).
1. Measurement of Bioavailability:
Direct and indirect methods may be used to assess drug bioavailability. The in-vivo bioavailability of a drug product is demonstrated by the rate and extent of drug absorption, as determined by comparison of measured parameters, e.g., concentration of the active drug ingredient in the blood, cumulative urinary excretion rates, or pharmacological effects.
For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action.
The design of the bioavailability study depends on the objectives of the study, the ability to analyze the drug (and metabolites) in biological fluids, the pharmacodynamics of the drug substance, the route of drug administration, and the nature of the drug product.
Pharmacokinetic and/or pharmacodynamic parameters as well as clinical observations and in-vitro studies may be used to determine drug bioavailability from a drug product.
1.1. Pharmacokinetic methods:
These are very widely used and based upon the assumption that the pharmacokinetic profile reflects the therapeutic effectiveness of a drug. Thus these are indirect methods. The two major pharmacokinetic methods are:
The major pharmacokinetic methods are:
Plasma / blood level time profile.
o Time for peak plasma (blood) concentration (t max)
o Peak plasma drug concentration (Cmax)
o Area under the plasma drug concentration–time curve (AUC)
Urinary excretion studies.
o Cumulative amount of drug excreted in the urine (Du)
o Rate of drug excretion in the urine (dDu/dt)
o Time for maximum urinary excretion (t)
C. Other biological fluids
1.2. Pharmacodynamic methods:
IT involves direct measurement of drug effect on a (patho) physiological process as a function of time. Disadvantages of it may be high variability, difficult to measure, limited choices, less reliable, more subjective, drug response influenced by several physiological & environmental factors.
They involve determination of bioavailability from:
Acute pharmacological response.
Therapeutic response.
1.3. In-vitro dissolution studies
Closed compartment apparatus
Open compartment apparatus
Dialysis systems.
1.4. Clinical observations
Well-controlled clinical trials
DISSOLUTION
Dissolution is defined as a process in which a solid substance solubilises in a given solvent.
(i.e. mass transfer from the solid surface to the liquid phase.)
Three Theories:
Diffusion layer model / Film theory
Danckwert’s model / Penetration or Surface renewal theory
Interfacial barrier model / Double barrier or Limited solvation theory
introduction
mechanisms of protein drug binding
binding of drugs
binding of drugs to blood components
determination of protein drug binding
factors affecting
significance
includes different mechanism involved in the absorption of the drug s into the systemic circulation. different factors affecting absorption including characters of drugs and different dosage forms. bioavailability of different dosage forms
Dissolution apparatus, invivo-invitro corelation, factor affecting,BCS classification ..
Complete dissolution topic in this slide & easy way to write..
Cheak it now and give feedback
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. Dissolution
The transfer of molecules or ions from a solid state into solution is
known as dissolution.
Dissolution and then diffusion is a Pre-requisite for the drug
absorption.
Physicochemically, ‘‘Dissolution is the process by which a solid
substance enters the solvent phase to yield a solution’’.
Dissolution (release of the drug from the dosage form) is of primary
importance for all conventionally constructed, solid oral dosage forms in
general, and for modified-release dosage forms in particular, and can be
the rate limiting step for the absorption of drugs administered orally.
5. Dissolution tests become especially important if dissolution is the rate-
limiting step in drug absorption, e.g., in rapidly disintegrating tablets or
capsules.
From a Quality Control perspective, dissolution testing is mainly used
to confirm product quality and batch-to-batch consistency and to identify
good and bad formulations.
Dissolution tests are used to confirm compliance with compendial
(summary of a larger work) specifications and are therefore needed as
part of a marketing authorization.( e.g. Disprin fast dissolving tablet).
Dissolution testing is widely used in the pharmaceutical industry for
optimization of formulation and quality control.
IMPORTANCE OF DISSOLUTION STUDY
6. Additionally they are used during product development and stability
testing as part of the development specification for the product. Critically
from an R&D perspective, there is the potential to correlate in vitro
dissolution data with in vivo bioavailability, which would greatly
facilitate product development.
Most sensitive and reliable predictors of in-vivo availability.
Such models can be used to screen potential drug and their associated
formulations for dissolution and absorption characteristics.
Dissolution study also identify potential bioavailability problems.
7. Dissolution testing as a QC test, to guide formulation development, to
use as a manufacturing/process control tool.
Dissolution also act as a quality control tool for the uniformity and
reproducibility of the batches.
Increasingly, in vitro dissolution testing and profile comparison are
relied on to assure product quality and performance and to provide a
biowaiver.( Biowaiver is the official approval for exemption from
conducting a bioequinalence study in the context of an application for
marketing authorization).
Dissolution studies are used to substitute bioabsorption (in-vivo)
where in-vivo in-vitro corelation are observed.
OBJECTIVES OF DISSOLUTION TESTING
8. It is research tool to optimize the parameters and ingredients in new
formulations.
It is also used to assess drug product quality with respect to stability
and shelf life.
To develop a composition and process for Phase I clinical studies
which are consistent with the intended market composition (qualitative
and quantitative).
To develop a highly discriminating dissolution test; not as a quality
control tool but as an aid to optimization of a formulation.
To develop a dosage form with a consistently high performance
throughout its life.
To develop a dissolution test to serve as a quality control tool.
9.
10. Diffusion layer model/Film Theory
It is a simplest model where dissolution of crystal,
immersed in liquid takes place without involving reactive
or electrical forces. Consist of two consecutive steps:
1. Solution of the solid to form a thin film or layer at
thesolid / liquid interface called as stagnant film
ordiffusion layer which is saturated with the drug this step
is usually rapid (instantaneous).
2. Diffusion of the soluble solute from the stagnant
layer to the bulk of the solution this step is slower and is
therefore the rate determining step in the
drugdissolution.
Theories of Dissolution
11.
12. dc/dt =DAKw/o (Cs- Cb) /Vh
Where,
D= diffusion coefficient of drug.
A= surface area of dissolving solid.
Kw/o= water/oil partition coefficient of
drug.
V= volume of dissolution medium.
h= thickness of stagnant layer.
(Cs – Cb )= conc. gradient for diffusion of
drug
Modified Noyes & Whitney equation
13. DANCKWERT’S MODEL (PENETRATION OR SURFACE RENEWALTHEORY)
The model could be visualized as a very thin film having a conc. Ci which is
less than saturation, as it is constantly being exposed to fresh surfaces of
liquid having a conc. much less than Ci. Acc. to model, the agitated fluid
consist of mass of eddies or packets that are continuously being exposed to
new surfaces of solidand then carried back to bulk of liquid.
14. Interfacial barrier model (double barrier or limited salvation
theory)
Based on salvation mechanism & solubility rather than
diffusion.
When considering the dissolution of the crystal will have
a different interfacial barrier given by following equation,
G = ki (Cs – Cb)
Where G = dissolution per unit area
Ki = effective interfacial transport constant
In this theory, the diffusivity D may not be independent
of saturation conc. Cs .
The interfacial barrier model can be extended to both
diffusion layer model and the Dankwert’s model.
15. Factors affecting dissolution and
dissolution rate
Physicochemical properties of drug : solubility,
particle size, polymorphism, salt formation,
complexation, wettability.
Dosage form factors: formulation factors and
excipients.
R= dc/dt=2.24Cs
Where R= dissolution rate.
> 1% aq. Solubility avoid B.A. problems.
16. Particle size and S.A. of drug
Absolute surface area: Total area of solid surface.
Effective surface area: Area of solid surface exposed.
Micronisation (<0.1 um) increase energy and increase
interaction, increase surface area and dissolution rate.
Micronisation of
Non hydrophobic drugs, poorly aq. Soluble drugs increase
dissolution rate. E.g. griseofulvin, chloramphenicol and
tetracyclin.
Physical-Chemical Factors Affecting
Dissolution
18. Polymorphism and Amorphism
Stable : low energy, high M.P. least aq. Solubility.
Metastable: high energy, low M.P. and high Aq.
Solubilities, better B.A.
E.g. chloramphenicol palmitate B ( A,B,C)
Riboflavin III (I,II,III)
Metastable to stable ; by dehydrating the molecular
environment, by adding viscosity building agent like
PVP,CMC.
Amorphous; high Aq. Solubility.
E.g. amorphous form of novobiosin, chloramphenicol,
cortisone acetate and phenobarbitol.
Amorphous > metastable > stable.
19. Hydrates/Solvates
Solvates : molecular adduct where the solvent
molecules are incorporated in crystal lattice .
Hydrates: solvent water.
Anhydrous form (high energy state): greater aq.
Solubility.
E.g. theophylline and ampicilline.
Organic solvate : more Aq. Solubility than non solvate
E.g. n-pentanol solvate of fludrocortisone
Chloroform solvate of griseofulvin.
20. Salt Form of the Drug
Solubility is pH dependent.
Weak acidic drug: strong base salt prepared
Solubility in diffusion layer is greater
Higher pH favors solubility of weak acid.
pH of diffusion layer (salt form) > bulk solution (free
acid)
E.g. Na and K salt of barbiturate and sulfonamide.
Weak basic drug : strong acid salt
E.g. HCL salt of alkaloids.
Solubility in diffusion layer is greater
Lower pH favors solubility of weak base.
pH of diffusion layer (salt form) < bulk solution (free
acid)
21. Salt Form of the Drug
Increased solubility is due to precipitation of drug as very
fine particles in bulk solution.
Size of the counter ion of the drug also influence solubility,
small size--- high solubility.
Novobiosine Na > Ca> acid. 50:25:1.
More soluble salt: poor bioavailability.
Na phenobarbital < free phenobarbital.
Due to not disintegration of the tablet.
23. Drug stability
Poor B.A. due to destabilization of drug during its shelf life is
due to
Degradation of drug in to inactive form
Interaction with one or more different component
24. pH - Partition Theory:
- According to the pH-partition hypothesis, the
gastrointestinal epithelia acts as a lipid barrier towards
drugs which are absorbed by passive diffusion, and those
that are lipid soluble will pass across the barrier.
- As most drugs are weak electrolytes, the unionized form of
weakly acidic or basic drugs (the lipid-soluble form) will
pass across the gastrointestinal epithelia, whereas the
gastrointestinal epithelia is impermeable to the ionized
(poorly-lipid soluble) form of such drugs.
- Consequently, the absorption of a weak electrolyte will be
determined by the extent to which the drug exists in its
unionized form at the site of absorption.
25. DRUG pKa AND GI pH:
Amount of drug that exists in un-ionized form and in ionized form is
a function of pKa of drug and pH of the fluid at the absorption site,
and it can be determined by Handerson-Hasselbach equation:
For weak acids,
pH = pKa + log [ionized]
[un-ionized]
% Drug ionized = 10pH-pKa x 100
1+10pH-pKa
For weak bases, pH = pKa + log [un-ionized]
[ionized]
% Drug ionized = 10pKa-pH x 100
1+10pKa-pH
26. Lipid solubility of drugs:
- Some drugs are poorly absorbed after oral administration
even though they are non-ionized in small intestine. Low
lipid solubility of them may be the reason.
- The best parameter to correlate between water and lipid
solubility is partition coefficient.
Partition coefficient (p) = [ L] conc / [W] conc
where, [ L] conc is the concentration of the drug in lipid
phase.
[W] conc is the concentration of the drug in aqueous phase.
- The higher p value, the more absorption is observed.
27. DRUG PRODUCT FORMULATION FACTORS
1. DILUENTS:
•Dissolution rate of salicylic acid tablet by
dry double compression process shows
three times increase in dissolution rate
when the starch content increase from the 5
– 20 %.
•Starch particles form a layer on the outer
surface of hydrophobic drug particles
resulting in imparting hydrophilic
character granules & thus increase in
effective surface area & rate of dissolution.
•Dissolution rate is also affected by excipient dilution (drug/excipient
ratio).E.g. in quinazoline comp. dissolution rate increases as the
excipient /drug ratio increases from 3:1 to 7:1 to 11:1.
28. 2. DISINTEGRANTS:
• Added before & after the granulation affects the dissolution rate.
e.g. Na CMC, MCC, Starch, etc.
3. BINDERS AND GRANULATING AGENTS:
• Hydrophilic binder show better dissolution profile with hydrophobic
drug like Phenacetin by implanting hydrophilic properties to granule
surface.
• Large amt. of binder increase hardness & decrease disintegration
/dissolution rate of tablet.
• Phenobarbital tablet granulated with gelatin solution provide a faster
dissolution rate in human gastric juice than those prepared using Na –
carboxymethyl cellulose or polyethylene glycol 6000 as binder.
29. 4. LUBRICANTS:
• Nature, quality, quantity of lubricant can affect dissolution rate.
Effect of Magnesium Stearate on dissolution of salicylic acid tablet.
•It should be added in small amount (1% or less) and should be tumbled
or mixed gently for only very short time. Prolonged mixing will increase
the dissolution time.
30. 5. SURFACTANTS:
•They enhance the dissolution rate of poorly soluble drug. This is due to
lowering of interfacial tension, increasing effective surface area, which
in turn results in faster dissolution rate.
•E.g Non-ionic surfactant Polysorbate 80 increase dissolution rate of
phenacetin granules.
6. COATING POLYMERS:
• Tablets with MC coating were found to exhibit lower dissolution
profiles than those coated with HPMC at 37ºC.